Lao People's Democratic Republic vs Senegal: The number of people with susceptibility test result for rifampicin
Lao People's Democratic Republic
3,796
in 2021
Senegal
3,191
in 2021
Lao People's Democratic Republic rank
36th
Senegal rank
38th
The number of people with susceptibility test result for rifampicin over time
- Lao People's Democratic Republic
- Senegal
How they compare
Lao People's Democratic Republic currently reports 3,796 against 3,191 in Senegal, a difference of 605.
That makes Lao People's Democratic Republic's figure about 1.2 times Senegal's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Senegal ahead.
Lao People's Democratic Republic ranks 36th and Senegal ranks 38th of 155 countries.
Lao People's Democratic Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,477 | 2,385 | 91.67 | Lao People's Democratic Republic |
| 2020s | 3,803 | 2,388 | 1,414 | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lao People's Democratic Republic or Senegal?
- Lao People's Democratic Republic, at 3,796 against 3,191 in Senegal as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lao People's Democratic Republic and Senegal?
- 605, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Senegal?
- 5 years are reported by both, from 2017 to 2021.
- How do Lao People's Democratic Republic and Senegal rank globally for the number of people with susceptibility test result for rifampicin?
- Lao People's Democratic Republic ranks 36th and Senegal ranks 38th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.